Alterity Therapeutics (ATHE) Invested Capital (2017 - 2018)

Alterity Therapeutics (ATHE) has 2 years of Invested Capital data on record, last reported at $13.7 million in Q2 2018.

  • For Q2 2018, Invested Capital fell 22.85% year-over-year to $13.7 million; the TTM value through Jun 2018 reached $13.7 million, down 22.85%, while the annual FY2018 figure was $13.7 million, 23.14% down from the prior year.
  • Invested Capital reached $13.7 million in Q2 2018 per ATHE's latest filing, down from $17.8 million in the prior quarter.
  • Across five years, Invested Capital topped out at $17.8 million in Q2 2017 and bottomed at $13.7 million in Q2 2018.